Oxidized LDL and atherogenesis

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 134-137

  Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS;

EID: 0032780762     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09231.x     Document Type: Conference Paper

References (15)

1. 1. TUOMILEHTO, J. & K. KUULASMAA. 1989. WHO Monica Project: Assessing CHD mortality and morbidity. Int. J. Epidemiol. 18(3 Suppl 1): S38-45.
2. 2. STEINBERG, D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
3. 3. YLÄ-HERTTUALA, S., W. PALINSKI, M.E. ROSENFELD, S. PARTHASARATHY, T.E. CAREW, S. BUTLER, J.L. WITZTUM & D. STEINBERG. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
4. 4. YLÄ-HERTTUALA, S. 1998. Is oxidized low-density lipoprotein present in vivo? Curr. Opin. Lipidol. 9: 337-344.
5. 5. BECKMAN, J.S., T.W. BECKMAN, J. CHEN, P.A. MARSHALL & B.A. FREEMAN. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Med. Sci. 87: 1620-1624.
6. 6. KODAMA, T., M. FREEMAN, L. ROHRER, J. ZABRECKY, P. MATSUDAIRA & M. KRIEGER. 1990. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 343: 531-535.
7. 7. ESTERBAUER, H., J. GEBICKI, H. PUHL & G. JURGENS. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13: 341-390.
8. 8. BERLINER, J.A., M. NAVAB, A.M. FOGELMAN, J.S. FRANK, L.L. DEMER, P.A. EDWARDS et al. 1995. Atherosclerosis. Basic mechanisms: oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
9. 9. SALONEN, J.T., S. YLÄ-HERTTUALA, R. YAMAMOTO, S. BUTLER, H. KORPELA, R. SALONEN, K. NYYSSÖNEN, W. PALINSKI & J.L. WITZTUM. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
10. 10. PALINSKI, W., M.E. ROSENFELD, S. YLÄ-HERTTUALA, G.C. GURTNER, S.S. SOCHER, S.W. BUTLER, S. PARTHASARATHY, T.E. CAREW, D. STEINBERG & J.L. WITZTUM. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86: 1372-1376.
11. 11. YLÄ-HERTTUALA, S., S. BUTLER, S. PICARD, W. PALINSKI, D. STEINBERG & J.L. WITZTUM. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14: 32-40.
12. 12. CAREW, T.E., D.C. SCHWENKE & D. STEINBERG. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabc heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84: 7725-7729.
13. 13. VERLANGIERT, A.J. & M.J. BUSH. 1992. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11: 131-138.
14. 14. BJÖRKHEM, I., A. HENRIKSSON-FREYSCHUSS, O. BREUER, U. DICZFALUSY, L. BERGLUND & P. HENRIKSSON. 1991. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11: 15-22.
15. 15. SPARROW, C.P., T.W. DOEBBER, J. OLSZEWSKI, M.S. WU, J. VENTRE, K.A. STEVENS & Y.S. CHAO. 1992. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89: 1885-1891.